Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial encephalomyopathies: an update.

Salvatore DiMauro1, Michio Hirano

  • 1Department of Neurology, Columbia University Medical Center, College of Physicians and Surgeons, Room 4-420, 630 West 168th Street, New York, NY 10032, USA. sd12@columbia.edu

Neuromuscular Disorders : NMD
|March 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical utility of functional testing in fibroblasts to diagnose primary mitochondrial disease.

medRxiv : the preprint server for health sciences·2026
Same author

Disease burden of untreated thymidine kinase 2 deficiency: insights from a large patient dataset.

Brain communications·2026
Same author

Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency.

Brain communications·2026
Same author

Enrichment of Rare Mitochondrial DNA Variants Among Individuals With Kidney Disease Reveals Undiagnosed Mitochondrial Disease.

Kidney international reports·2026
Same author

Diagnostic Criteria and Management of MELAS and Stroke-Like Episodes: Consensus-Based Statements.

European journal of neurology·2026
Same author

4,5-dihydroxyhexanoic acid is a robust circulating and urine marker of mitochondrial disease and its severity.

bioRxiv : the preprint server for biology·2026
Same journal

Aquatic training improves muscle strength and functional mobility in adults with myotonic dystrophy type 1: a pilot randomized trial.

Neuromuscular disorders : NMD·2026
Same journal

Severe dilated cardiomyopathy in females with dystrophinopathy : a case series of nine patients.

Neuromuscular disorders : NMD·2026
Same journal

A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment.

Neuromuscular disorders : NMD·2026
Same journal

Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.

Neuromuscular disorders : NMD·2026
Same journal

Longitudinal functional trajectories in Duchenne muscular dystrophy: outcome-specific patterns from a registry-based modelling study.

Neuromuscular disorders : NMD·2026
Same journal

HACD1-related congenital myopathy skeletal muscle MRI findings in a Brazilian cohort.

Neuromuscular disorders : NMD·2026
See all related articles

Recent advances in mitochondrial encephalomyopathies reveal new genetic mutations and pathogenic mechanisms. Research highlights mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) defects, impacting cellular energy production and function.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Mitochondrial encephalomyopathies are classified based on genetic origin: mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) defects.
  • Understanding these complex genetic disorders is crucial for developing effective treatments.

Purpose of the Study:

  • To review recent progress in understanding genetic defects causing mitochondrial encephalomyopathies.
  • To highlight key discoveries in both mtDNA- and nDNA-related mitochondrial diseases.

Main Methods:

  • Literature review of recent advancements in mitochondrial disease genetics.
  • Analysis of newly identified mutations and pathogenic mechanisms.

Main Results:

  • Identified new pathogenic mutations in mtDNA, particularly in Complex I (ND genes).

Related Experiment Videos

  • Recognized the role of homoplasmic mutations and haplotypes in mtDNA diseases.
  • Discovered new mutations in nDNA-related mitochondrial diseases, including Complex I, IV, and V deficiencies.
  • Elucidated mechanisms of intergenomic communication disorders, mtDNA deletions/depletion, and translation defects.
  • Highlighted the importance of cardiolipin and mitochondrial dynamics (motility, fission, fusion) in disease pathogenesis.

    • Conclusions:

    • Significant progress has been made in identifying genetic causes of mitochondrial encephalomyopathies.
    • New insights into molecular mechanisms offer potential therapeutic targets.